3D-printed mini-brains to track how brain cells move
An Engineered Bioprinting Platform to Study Neural Migration in Assembloids
Researchers are building better 3D-printed mini-brains so we can see how brain cells migrate in Alzheimer's and other brain disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11321275 on NIH RePORTER |
What this research studies
Lab-grown mini-brains called organoids can model brain tissue but normally miss how different brain regions interact. This project combines separate region organoids into 'assembloids' and uses engineered 3D bioprinting to place and support them in controlled shapes and positions. The team aims to reduce variability from manual handling and messy support gels, and to make more complex multi-region assembloids that better mimic real brain geometry. Improved models could help researchers study how nerve cells move and connect in diseases like Alzheimer's and some neurodevelopmental disorders.
Who could benefit from this research
Good fit: People with Alzheimer's disease or related neurodevelopmental conditions, or those able to donate blood or skin samples for lab-derived cells, would be most connected to this work.
Not a fit: Patients seeking immediate changes to their care or new clinical treatments should not expect direct benefit because this is preclinical lab model development.
Why it matters
Potential benefit: If successful, this could create more reliable lab models that speed discovery of disease mechanisms and future treatments for Alzheimer's and related brain conditions.
How similar studies have performed: Previous organoid and assembloid studies have revealed migration and connectivity problems in some disorders, but using engineered 3D bioprinting to make reproducible, complex assembloids is a more novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Heilshorn, Sarah C — Stanford University
- Study coordinator: Heilshorn, Sarah C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.